skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.
Date 2019-03-19 Hit 578
News List
Prev Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.
Next The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox